An anti-EGF monoclonal antibody that detects intramolecular communication in factor IX

Biochemical and Biophysical Research Communications

Volumn 286, Issue 5, 2001, Pages 1039-1044

  Persson, K E M ^a   Knobe, K E ^b   Stenflo, J ^a  

^a Department of Clinical Chemistry ^*  (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Coagulation; EGF; Factor IX; Interaction; Module; Monoclonal antibody

Indexed keywords

4 CARBOXYGLUTAMIC ACID; BLOOD CLOTTING FACTOR 9; EPIDERMAL GROWTH FACTOR ANTIBODY; MONOCLONAL ANTIBODY; RECOMBINANT BLOOD CLOTTING FACTOR 9; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANTIGEN ANTIBODY COMPLEX; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; BINDING AFFINITY; BLOOD CLOTTING; CARBOXY TERMINAL SEQUENCE; ENZYME ACTIVE SITE; MUTATION; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN LOCALIZATION;

EID: 0034811245     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2001.5398     Document Type: Article

References (25)

1. FIX and Hemophilia B
2. Blood coagulation
3. Activation of bovine factor IX (Christmas factor) by factor XIa (activated plasma thromboplastin antecedent) and a protease from Russel's viper venom
4. Blood coagulation factor IX residues Glu78 and Arg 94 provide a link between both epidermal growth factor-like domains that is crucial in the interaction with factor VIII light chain
5. Hydrophobic contact between the two epidermal growth factor-like domains of blood coagulation factor IX contributes to enzymatic activity
6. 2+-free GLA domain sheds light on membrane binding of blood coagulation proteins
7. 2+ binding to the first EGF domain. A combined NMR-small angle X-ray scattering study
8. Factor IX Hollywood: Substitution of Pro55 by Ala in the first epidermal growth factor-like domain
9. The role of β-hydroxyaspartate and adjacent carboxylate residues in the first EGF domain of human factor IX
10. Haemophilia B: Database of point mutations and short additions and deletions, eighth edition
11. Activation and active site occupation alter conformation in the region of the first EGF domain of human factor VII
12. Polymorphism of normal factor IX detected by mouse monoclonal antibodies
13. Identification and purification of vitamin K-dependent proteins and peptides with monoclonal antibodies specific for γ-carboxy-glutamyl (Gla) residues
14. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
15. Characterization of recombinant EGF modules from vitamin K-dependent protein S expressed in Spodoptera cells. The cofactor activity depends on the N-terminal EGF module in human protein S
16. Calcium binding properties of the third and fourth epidermal-growth-factor-like modules in vitamin-K-dependent protein S
17. How an epidermal growth factor (EGF)-like domain binds calcium. High resolution NMR structure of the calcium form of the NH2-terminal EGF-like domain in coagulation factor X
18. 2+-binding epidermal growth factor-like domain: Its role in protein-protein interactions
19. 2+-binding to the first epidermal growth factor-like domain of human blood coagulation factor IX promotes enzyme activity and factor VIII light chain binding
20. Protease and EGF1 domains of factor IXa play distinct roles in binding to factor VIIIa
21. Expression and characterization of human factor IX and factor IX-factor X chimeras in mouse C127cells
22. Replacing the first epidermal growth factor-like domain of factor IX with that of factor VII enhances activity in vitro and in canine hemophilia B
23. 2+ binding to the first epidermal growth factor-like domain of factor VIIa increases amidolytic activity and tissue factor affinity
24. 2+ binding to the first epidermal growth factor module of coagulation factor VIIa is important for cofactor interaction and proteolytic function
25. X-ray structure of clotting factor IXa: Active site module structure related to Xase activity and hemophilia